As in vivo studies have demonstrated the neuroprotective actions of insulin in ameliorating 6-OHDA-induced motor behavioural impairments, the therapeutic potential of nasally administered insulin should be further explored in different neurological disorders such as PD and neuronal injury [100]. The gene discussed is INS; the disease is nervous system disorder.